Naaju Breaking News, Live Updates, Latest Headlines, Viral News, Top Stories, Trending Topics, Videos
[ad_1]
The National Health Surveillance Agency (Anvisa), the regulatory body Brazil, today announced that it is now able to grant temporary authorization for emergency use and covid-19 vaccines.
Now, public or private laboratories can try Anvisa to apply for authorization to initiate specific vaccinations without needing the entire registration process.
The announcement was made when Anvisa still has not received any orders vaccine against the coronavirus to operate in Brazil.
On December 15, the Butantan Institute, in the state of São Paulo, which locally develops the Chinese vaccine Coronavac, from the Sinovac laboratory, which today began to be packaged in its vaccine production plant, will present the trials of safety and efficacy.
In an emergency, Anvisa can now accept the operation request.
Alessandra Bastos Soares, Director of Anvisa, indicated that “emergency use authorization is a mechanism that can facilitate the availability and use of covid-19 vaccines, although they have not been assessed under the registry filter, provided they meet the minimum requirements for safety, quality and effectiveness “.
The official said the regulator can change, suspend or cancel the temporary authorization at any time.
The government has not yet presented a national vaccination, despite the fact that he has a batch of more than 100 million doses in February by the laboratory Astrazeneca, which develops the English vaccine Oxford.
Health Minister Eduardo Pazuello said yesterday he was in negotiations with Pfizer of the United States to acquire 70 million doses.
In this context, in the so-called political war of vaccinations, San Pablo state governor Joao Doria today asked President Bolsonaro to incorporate Coronavac into the vaccination schedule, as a vaccination campaign in São Paulo has been announced for January 25.
The Butantan Institute in São Paulo today started production, packaging and labeling on local soil with the 600 liters that arrived from China for the production of one million doses.
To the 245 employees of the public laboratory, 160 others will be incorporated so that the production takes place during the 24 hours.
By February, 40 million doses are expected to be produced at the Butantan Institute, which has the largest public vaccine plant in the southern hemisphere.
In the meantime, the Ministry of Education has accepted the recommendation of the National Council of Education to postpone until the end of the pandemic the authorization of all levels of education, both public and private, not to have the obligation to use face-to-face courses.
It is a political defeat against the bolonarist wing of the ministry, which tried, in vain, to anticipate face-to-face courses for January in federal universities.
.
[ad_2]
Source link
